Therapeutics MD's Annovera (Segesterone Acetate/Ethinyl Estradiol) Receives FDA Approval for the Prevention of Pregnancy
Shots:
- The approval is based on 17 clinical trials results assessing Annovera in 2-308 women aged ≤35yrs
- The study demonstrated in prevention of 97.3% pregnancy- Pearl Index (PI) 2.98/100 women with overall satisfaction rate is 89%
- Annovera is a combination of estrogen (ethinyl estradiol- 0.15 mg/day) & Nestorone (segesterone acetate-0.013 mg/day) used for prevention of ovulation for a year (13 cycle) without any medical help
Ref: Therapeutics MD | Image: Benzinga
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com